Total Lymphocyte Count, Hemoglobin, and Delayed-Type Hypersensitivity as Predictors of Death and AIDS Illness in HIV-1-Infected Women Receiving Highly Active Antiretroviral Therapy

Kathryn Anastos, Quihu Shi, Audrey L. French, Alexandra Levine, Ruth M. Greenblatt, Carolyn Williams, Jack DeHovitz, Robert Delapenha, Donald R. Hoover

Research output: Contribution to journalArticlepeer-review

55 Scopus citations

Abstract

Background: Total lymphocyte count (TLC) and hemoglobin level have been suggested as useful and inexpensive parameters to indicate need for HAART in settings in which CD4+ cell counts are unavailable. If delayed-type hypersensitivity (DTH) response predicts clinical response in persons using highly active antiretroviral therapy (HAART), it may also prove useful in resource-poor settings. Objective: To examine whether TLC, hemoglobin, and DTH response observed prior to initiation of HAART predict post-HAART clinical response. Design: Prospective cohort study. Participants: 873 women in the Women's Interagency HIV Study. Measurements: TLC, hemoglobin, CD4+ cell counts, and DTH testing using mumps, candida, and tetanus toxoid antigens, performed within 1 year prior to HAART initiation; death; self-report of initiation of HAART use and AIDS-defining illness (ADI). Results: Three different multivariate analyses were performed: 2 models that excluded CD4 + cell count and assessed TLC at either <850 or <1250 cells/μL, and 1 model that excluded TLC and included CD4+ <200 cells/μL. TLC <850, TLC <1250, CD4+ <200 cells/μL, anergy to DTH testing, hemoglobin <10.6 g/dL, and a pre-HAART report of ADI were each consistently independently associated both with death and with incident ADI. Log likelihood χ2 values suggested similar power among the 3 models in predicting both death and incident ADI. Conclusions: Pre-HAART TLC, hemoglobin level, anergy to DTH testing, and clinical disease each independently predicted morbidity and death after HAART initiation. These findings support the use of TLC to guide decision-making for HAART initiation and suggest that further study of TLC, hemoglobin level, and DTH responses as an indication to provide HAART may be useful in resource-limited settings.

Original languageEnglish (US)
Pages (from-to)383-392
Number of pages10
JournalJournal of Acquired Immune Deficiency Syndromes
Volume35
Issue number4
DOIs
StatePublished - Apr 1 2004

Keywords

  • Disease progression
  • HIV
  • Highly active antiretroviral therapy
  • Survival
  • Total lymphocyte count

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Total Lymphocyte Count, Hemoglobin, and Delayed-Type Hypersensitivity as Predictors of Death and AIDS Illness in HIV-1-Infected Women Receiving Highly Active Antiretroviral Therapy'. Together they form a unique fingerprint.

Cite this